HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yanyu Wang Selected Research

Hepatitis B

1/2023Biomarkers of gut barrier dysfunction and risk of hepatocellular carcinoma in the REVEAL-HBV and REVEAL-HCV cohort studies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yanyu Wang Research Topics

Disease

21Neoplasms (Cancer)
02/2024 - 05/2016
13Hepatocellular Carcinoma (Hepatoma)
02/2024 - 08/2021
7Biliary Tract Neoplasms (Biliary Tract Cancer)
09/2023 - 01/2021
5Cholangiocarcinoma
01/2024 - 01/2022
5Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
04/2021 - 01/2018
4Hypoxia (Hypoxemia)
03/2024 - 01/2022
4Disease Progression
11/2023 - 01/2021
4Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2022 - 06/2014
3Infections
11/2023 - 07/2021
3Acute Coronary Syndrome
11/2023 - 01/2020
3Thrombosis (Thrombus)
07/2023 - 06/2014
3Neoplasm Metastasis (Metastasis)
07/2023 - 01/2019
3Liver Neoplasms (Liver Cancer)
07/2023 - 05/2023
3COVID-19
01/2023 - 07/2021
3Coronary Artery Disease (Coronary Atherosclerosis)
01/2019 - 08/2014
2Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome)
10/2023 - 12/2021
2Carcinoma (Carcinomatosis)
07/2023 - 01/2022
2Cognitive Dysfunction
03/2023 - 01/2021
2Cytokine Release Syndrome
01/2023 - 12/2021
2Inflammation (Inflammations)
08/2022 - 12/2019
2Hypertension (High Blood Pressure)
08/2022 - 08/2021
2Fatigue
08/2022 - 08/2021
2Leukemia
01/2022 - 01/2022
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
08/2020 - 01/2019
1Microsatellite Instability
01/2024
1Insulin Resistance
11/2023
1Hepatitis B
01/2023
1Liver Diseases (Liver Disease)
01/2023
1Cytopenia
01/2023
1Gallbladder Neoplasms (Gallbladder Cancer)
08/2022
1Carcinogenesis
01/2022
1Colonic Neoplasms (Colon Cancer)
01/2022
1Genomic Instability
01/2022
1Ischemia
01/2022
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2022
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2022
1Reperfusion Injury
01/2022
1Hyperferritinemia
12/2021
1Neutropenia
12/2021
1Hyperbilirubinemia
12/2021
1Hypertriglyceridemia
12/2021

Drug/Important Bio-Agent (IBA)

11Immune Checkpoint InhibitorsIBA
02/2024 - 01/2022
11lenvatinibIBA
10/2023 - 01/2022
8Biomarkers (Surrogate Marker)IBA
02/2024 - 01/2019
7Proteins (Proteins, Gene)FDA Link
11/2023 - 05/2015
4Long Noncoding RNAIBA
01/2022 - 01/2018
4Brain-Derived Neurotrophic Factor (BDNF)IBA
04/2021 - 01/2018
3AntibodiesIBA
01/2023 - 08/2021
3CytokinesIBA
08/2022 - 06/2019
2DNA (Deoxyribonucleic Acid)IBA
02/2024 - 01/2021
2B7-H1 AntigenIBA
02/2024 - 01/2024
2Triglycerides (Triacylglycerol)IBA
11/2023 - 03/2023
2Glucose (Dextrose)FDA LinkGeneric
11/2023 - 03/2023
2Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
10/2023 - 01/2023
2AntigensIBA
01/2023 - 01/2022
2ChromatinIBA
01/2023 - 07/2021
2histone H3 trimethyl Lys4IBA
01/2023 - 07/2021
2toripalimabIBA
01/2023 - 01/2023
2Chimeric Antigen ReceptorsIBA
01/2023 - 12/2021
2RNA (Ribonucleic Acid)IBA
01/2022 - 10/2020
2Circular RNAIBA
01/2022 - 01/2019
2Histones (Histone)IBA
04/2021 - 01/2019
2KetamineFDA LinkGeneric
01/2021 - 01/2018
2Ion Channels (Ion Channel)IBA
04/2020 - 01/2020
2Cyclic Nucleotide-Gated Cation ChannelsIBA
01/2020 - 01/2018
2Ethanol (Ethyl Alcohol)IBA
01/2019 - 01/2018
1Oxygen (Dioxygen)IBA
03/2024
1CateninsIBA
02/2024
1Indicators and Reagents (Reagents)IBA
11/2023
1Interleukin-18 (Interleukin 18)IBA
10/2023
168Ga-FAPIIBA
10/2023
1SeleniumIBA
05/2023
1Bevacizumab (Avastin)FDA Link
01/2023
1InterferonsIBA
01/2023
1EuchromatinIBA
01/2023
1MicroRNAs (MicroRNA)IBA
08/2022
1Interferon Type IIBA
08/2022
1BilirubinIBA
08/2022
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2022
1Azacitidine (5 Azacytidine)FDA Link
01/2022
1N-methyladenosineIBA
01/2022
1CarbohydratesIBA
01/2022
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
01/2022
1Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
01/2022
1Competitive Endogenous RNAIBA
01/2022
1oxalylglycineIBA
01/2022
1Netrin-1IBA
01/2022
1azacyclonolIBA
01/2022
1Transcription Factors (Transcription Factor)IBA
01/2022
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
12/2021
1GemcitabineFDA Link
12/2021

Therapy/Procedure

13Therapeutics
02/2024 - 01/2016
5Immunotherapy
01/2024 - 01/2021
5Drug Therapy (Chemotherapy)
09/2023 - 12/2021
3Stents
11/2023 - 06/2014
2Radiotherapy
07/2023 - 07/2023
2Drug-Eluting Stents
08/2014 - 06/2014
1Aftercare (After-Treatment)
01/2023
1Salvage Therapy
01/2023
1Subcutaneous Injections
01/2022